Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats.

[1]  M. Stolina,et al.  Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats. , 2015, Bone.

[2]  Yudong D. He,et al.  Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in Rats , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  D. Kohn,et al.  WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling* , 2015, The Journal of Biological Chemistry.

[4]  D. Burr,et al.  Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone , 2015, Proceedings of the National Academy of Sciences.

[5]  T. Mikkelsen,et al.  The Regulatory Landscape of Osteogenic Differentiation , 2014, Stem cells.

[6]  P. Kostenuik,et al.  Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats. , 2014, Bone.

[7]  P. Kostenuik,et al.  Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody. , 2014, Endocrinology.

[8]  Xuan-Yin Chen,et al.  Let-7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora-B. , 2014, International journal of clinical and experimental pathology.

[9]  Y. Katayama,et al.  Regulation of hematopoiesis in endosteal microenvironments , 2014, International Journal of Hematology.

[10]  Cesar Libanati,et al.  Romosozumab in postmenopausal women with low bone mineral density , 2014, The New England journal of medicine.

[11]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[12]  Jeffrey L. Wrana,et al.  Signal integration in TGF-β, WNT, and Hippo pathways , 2013, F1000prime reports.

[13]  W. Richards,et al.  Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. , 2012, Endocrine reviews.

[14]  Hai Qing,et al.  Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  N. Kim,et al.  MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling , 2012, Cell cycle.

[16]  Nam-Gyun Kim,et al.  p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling , 2011, Science Signaling.

[17]  Lynda F. Bonewald,et al.  Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway , 2011, PloS one.

[18]  E. Posvar,et al.  Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  H. Saya,et al.  c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis , 2010, Oncogene.

[20]  H. Smeets,et al.  Wnt5b stimulates adipogenesis by activating PPARgamma, and inhibiting the beta-catenin dependent Wnt signaling pathway together with Wnt5a. , 2009, Biochemical and biophysical research communications.

[21]  H. Kwak,et al.  GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway1 , 2009, The Journal of Immunology.

[22]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[23]  P. Williams.  A single dose , 2008, BDJ.

[24]  T. Yuan,et al.  The Retinoblastoma Protein Tumor Suppressor Is Important for Appropriate Osteoblast Differentiation and Bone Development , 2008, Molecular Cancer Research.

[25]  Matthew R Allen,et al.  Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin* , 2008, Journal of Biological Chemistry.

[26]  K. Coombes,et al.  Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression* , 2006, Journal of Biological Chemistry.

[27]  Stephen N. Jones,et al.  Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling , 2006, The Journal of cell biology.

[28]  Z. Weng,et al.  A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.

[29]  Qiang Wu,et al.  p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling , 2006, The Journal of cell biology.

[30]  J. Reeve,et al.  The FASEB Journal express article 10.1096/fj.05-4221fje. Published online August 25, 2005. ©2005 FASEB , 2022 .

[31]  J. Wysolmerski,et al.  TOPGAL Mice Show That the Canonical Wnt Signaling Pathway Is Active During Bone Development and Growth and Is Activated by Mechanical Loading In Vitro , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Hans Clevers,et al.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. , 2005, Developmental cell.

[33]  Asif J. Chaudhry,et al.  Ras-Raf-Arf Signaling Critically Depends on the Dmp1 Transcription Factor , 2005, Molecular and Cellular Biology.

[34]  M. Justice,et al.  A twist code determines the onset of osteoblast differentiation. , 2004, Developmental cell.

[35]  John A Latham,et al.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist , 2003, The EMBO journal.

[36]  M. West,et al.  Distinct gene expression phenotypes of cells lacking Rb and Rb family members. , 2003, Cancer research.

[37]  M. van Lohuizen,et al.  The T-box Repressors TBX2 and TBX3Specifically Regulate the Tumor Suppressor Genep14 ARF via a Variant T-site in the Initiator* , 2002, The Journal of Biological Chemistry.

[38]  T. Volkert,et al.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.

[39]  Toshitaka Nakamura,et al.  Disruption of the p53 Gene Results in Preserved Trabecular Bone Mass and Bone Formation After Mechanical Unloading , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  Charles J. Sherr,et al.  The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.

[41]  N. Athanasou,et al.  The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells. , 2001, Bone.

[42]  T. Takano-Yamamoto,et al.  A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. , 2001, Bone.

[43]  Marc J. van de Vijver,et al.  Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers , 2000, Nature Genetics.

[44]  Jian Wang,et al.  Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53 , 2000, Oncogene.

[45]  R. Eisenman,et al.  c-Myc enhances protein synthesis and cell size during B lymphocyte development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Kedes,et al.  Twist is a potential oncogene that inhibits apoptosis. , 1999, Genes & development.

[47]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[48]  A. Wetterwald,et al.  Role of CSF‐1 in bone and bone marrow development , 1997, Molecular reproduction and development.

[49]  M. Forwood,et al.  Inducible cyclo‐oxygenase (COX‐2) mediates the induction of bone formation by mechanical loading in vivo , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  R. Mehta,et al.  Skeletal effects of calcitonin in ovariectomized rats. , 1991, Endocrinology.

[51]  H. Frost.  Bone “mass” and the “mechanostat”: A proposal , 1987, The Anatomical record.

[52]  H. Gundersen.  Stereology of arbitrary particles * , 1986, Journal of microscopy.

[53]  D. C. Sterio.  The unbiased estimation of number and sizes of arbitrary particles using the disector , 1984, Journal of microscopy.

[54]  T. Bellido.  Osteocyte-Driven Bone Remodeling , 2013, Calcified Tissue International.

[55]  Luquan Wang,et al.  Generation of p53 target database via integration of microarray and global p53 DNA-binding site analysis. , 2004, Methods in molecular biology.